Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome

Children with Down syndrome (DS) are at a significantly higher risk of developing acute myeloid leukemia, also termed myeloid leukemia associated with DS (ML-DS). In contrast to the highly favorable prognosis of primary ML-DS, the limited data that are available for children who relapse or who have...

Descripción completa

Detalles Bibliográficos
Autores principales: Raghuram, Nikhil, Hasegawa, Daisuke, Nakashima, Kentaro, Rahman, Syaza, Antoniou, Evangelia, Skajaa, Torjus, Merli, Pietro, Verma, Anupam, Rabin, Karen R., Aftandilian, Catherine, Kotecha, Rishi S., Cheuk, Daniel, Jahnukainen, Kirsi, Kolenova, Alexandra, Balwierz, Walentyna, Norton, Alice, O’Brien, Maureen, Cellot, Sonia, Chopek, Ashley, Arad-Cohen, Nira, Goemans, Bianca, Rojas-Vasquez, Marta, Ariffin, Hany, Bartram, Jack, Kolb, E. Anders, Locatelli, Franco, Klusmann, Jan-Henning, Hasle, Henrik, McGuire, Bryan, Hasnain, Afia, Sung, Lillian, Hitzler, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632607/
https://www.ncbi.nlm.nih.gov/pubmed/36735769
http://dx.doi.org/10.1182/bloodadvances.2022009381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632607/
https://www.ncbi.nlm.nih.gov/pubmed/36735769
http://dx.doi.org/10.1182/bloodadvances.2022009381

Ejemplares similares